All Stories

What’s the Hype Surrounding GPT-3?

It’s only been about two months since GPT-3 was released by OpenAI, an artificial intelligence (AI) research organization backed by Elon...
3 min read 779

Injection For the Market – FAANG Continues to Ride That Perma-bu...

FAANG stocks pull the market higher on news of an FDA emergency greenlight on a COVID plasma treatment. After a week...
6 min read 209

These dividend pearls have been convincing investors for 100 years

Do you want stocks that pay out reliable bonuses? Then you should take a look at these two depots. Some stocks...
6 min read 240

Think Global, Act Local: 4 Keys For Startups To Expand Into New Market...

You are a startup that has done fantastic in your home market. Congratulations. Can you repeat it in new markets? This...
2 min read 224

DDI Highlights – Top 10 Must Reads this Week

DDI Contributor Highlights | Week of August 22 Before we get to this week’s top 10, we’d like to share a...
3 min read 215

Pfizer and Valneva Join Forces on Lyme Disease Vaccine

Lyme disease vaccine induces antibodies in Phase II clinical trial. SHORT SUMMARY: The engineered protein vaccine VLA15 induces multiple antibodies in a...
3 min read 273